物质信息

ID:1826724

名称和标识
IUPAC传统名
diovan
IUPAC标准名
(2S)-3-methyl-2-(N-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)butanoic acid
别名
valsartan(S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valineDiovanN-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valineN-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
国际非专利药品(INN)
valsartan
数据登录号
PubChem CID
60846
DrugBank ID
DB00177
LINCS数据库
LSM-2993
Reaxys Registry
7754038
PDB数据库
7bm1
SureChEMBL数据库
SCHEMBL2542
Beilstein号
7754038
HMDB数据库
HMDB0014323
维基百科标题
Valsartan
专利号
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
Drug Central Database
2,806
BindingDB数据库
50049186
KEGG DRUG Database
D00400
CHEBI ID
CHEBI:9927
PubChem SID
46530915
化合物性质
暂无数据
点击上传数据
描述信息
A monocarboxylic acid amide consisting of L-valine in which the amino hydrogens have been replaced by a pentanoyl and a [2'-(1H-tetrazol-5-yl)biphenyl]-4-yl]methyl group. It exhibits antihypertensive activity.
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据
导 航